USP and SAHPRA: A Partnership for Health Regulatory Excellence

By Staff Writer

September 14, 2023

The United States Pharmacopeia (USP) recently welcomed an executive delegation from the South African Health Products Regulatory Authority (SAHPRA) to its Rockville headquarters. This visit marked the culmination of a two-part series, during which both organisations exchanged ideas and explored areas of expanded technical collaboration.

Strengthening the Bond

In 2022, USP and SAHPRA signed a Memorandum of Understanding (MOU) aiming to expand the availability of health products that are safe, effective, and of assured quality. The partnership also seeks to support SAHPRA in achieving the World Health Organization Maturity Level 4, a status that distinguishes regulatory systems operating at the most advanced levels of performance.

The Road Ahead

SAHPRA CEO Dr. Boitumelo Semete-Makokotlela expressed optimism about the partnership. She stated that the collaboration with USP would bolster their ability to respond to today’s regulatory challenges using state-of-the-art science in quality assurance and regulatory practice.

A Commitment to Global Health

In December 2022, the Promoting the Quality of Medicines Plus (PQM+) program, funded by the U.S. Agency for International Development and implemented by USP, organized a joint workshop with SAHPRA. The workshop aimed to strengthen regulatory oversight of vaccines in the region as part of the U.S. Government’s Global VAX initiative.

About the Organizations

SAHPRA’s mandate includes regulating all health products, overseeing radiation control, and ensuring the safety, efficacy, and quality of medicines, medical devices, and in-vitro diagnostics (IVDs). Similarly, the USP is an independent, scientific nonprofit organisation working to strengthen the global supply chain for safe, quality medicines. The PQM+ Program is a cooperative agreement between USAID and USP to sustainably strengthen medical product quality assurance systems in low- and middle-income countries. 

Reference url

Recent Posts

Argentina WHO Withdrawal
   

Argentina WHO Withdrawal: President Milei Exits Global Health Alliance Amid COVID-19 Disputes

💡 *What happens when a country decides to withdraw from global health organizations?*
Argentina’s President Javier Milei has made the bold move to withdraw from the WHO, citing significant disagreements over health management during the pandemic. This decision raises questions about national sovereignty, cooperation, and the future of global health initiatives. Dive into the implications of Argentina’s stance and what it means for international health governance.

#SyenzaNews #globalhealth #healthcarepolicy

Gauteng HPV vaccination campaign
      

Gauteng HPV Vaccination Campaign: Protecting Girls Against Cervical Cancer

💉 Ready to protect our future generations from cervical cancer?

The Gauteng HPV vaccination campaign aims to vaccinate grade 5, 6, and 7 girls against the virus that causes most cervical cancers. By leveraging a single-dose regimen, this initiative not only enhances access to life-saving vaccines but also strives to meet ambitious global health targets.

Explore how this campaign is reshaping health outcomes in South Africa and why parental consent is key to its success.

#SyenzaNews #HealthEconomics #HealthcareInnovation #UniversalHealthCoverage

Capvaxive vaccine approval
     

Capvaxive Vaccine Approval

🌍 What if a single vaccine could significantly change the landscape of pneumococcal disease prevention in adults?

The European Medicines Agency has just recommended Merck’s Capvaxive, an innovative 21-valent pneumococcal conjugate vaccine! With robust data from multiple phase 3 trials, this potential approval marks a pivotal step in the fight against invasive Streptococcus pneumoniae infections in the EU. Look into how Capvaxive could enhance public health outcomes and offer extensive serotype coverage.

#SyenzaNews #pharmaceuticals #healthcarepolicy

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2025 Syenza™. All rights reserved.